MTEN - expected 1000% revenue increase in 97 Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MTEN - expected 1000% revenue increase in 97

MTEN 2.720

+6.7%

Nov 5 3:56 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Tom Hofmann who wrote (56)	1/21/1997 1:43:00 PM
From: Syd Deem	of 279

Hey guys! LANCASTER, Pa.--(BUSINESS WIRE)--Jan. 21, 1997-- Medical Technology & Innovations Inc announced today the appointment of Robert D. Brennan as President and Chief Operating Officer. Company founder Jeremy P. Feakins remains Chairman and Chief Executive Officer. Brennan, with 25 years experience in managing both large and small companies, has been Vice President-General Manager of the $58 million-sales Trubyte division of Dentsply International Inc , a $780 million-sales dental and medical product manufacturer and distributor. He was previously Vice President-General Manager of DENTSPLY's F&F Koenigkramer division, a fully integrated ophthalmological equipment company. Brennan was twice named General Manager of the Year by DENTSPLY. His previous posts included Vice President-Operations of the Deseret division of Warner Lambert Company, a hospital products manufacturer of IV catheters and operating room supplies with annual sales of $125 million. Brennan received a B.S. degree in Business Administration and an M.B.A. in Management Development from Drexel University. "It is a milestone in the development of our young company that Medical Technology has been able to attract a senior corporate executive with the tremendously successful track record of Bob Brennan," said Chairman Feakins. "As Chief Operating Officer, he will free me from day-to- day duties so that I may focus my energies where they really belong -- growing the company through strategic marketing of our unique patented products." Feakins also announced that the company's newly established UK office in London had received opening orders and indications for 10 MTI PhotoScreeners(TM). Feakins said that Polaroid Corp , Medical Technology's leading marketing partner, had agreed to distribute PhotoScreener(TM) information kits to approximately 5,000 eye doctors in the British Isles.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next